Studying the current state of the clinical approaches to bone diseases in breast cancer patients treated with adjuvant and/or hormone therapy

Inclusion Criteria:

• Patients willing to provide the Informed consent to participate to the study
• Women aged 18-75 years
• Patients having breast cancer, with no phenotype restrictions
• Patients in natural and stable menopause
• Patients having secondary amenorrhea, that arose after the initiation of oncologic treatment, since at least 12 months or 6 months with FSH> 40 U/I

Exclusion Criteria:

• Patients with advanced cancer and/or bone metastases and/or visceral metastases
• Patients with severe renal insufficiency and/or in dialysis and patients affected by severe endocrine disorders

Women

Women affected by breast cancer in menopause or with secondary amenorrhea arising from the initiation of oncologic treatments